Results 21 to 30 of about 126,067 (267)
Prevention and relief of symptoms by regular use of bronchodilators is central to the management of patients with chronic obstructive pulmonary disease (COPD). The bronchodilators in use are beta(2)-agonists, anticholinergics and theophylline.
Brusselle, Guy +3 more
core +3 more sources
To determine the cognitive and functional consequences of dual use of cholinesterase inhibitors (ChIs) and the bladder anticholinergics oxybutynin or ...
Kaycee M Sink +2 more
exaly +2 more sources
Srihari Gopal1, Joris Berwaerts1, Isaac Nuamah1, Kasem Akhras2, Danielle Coppola1, Ella Daly1, David Hough1, Joseph Palumbo11Johnson & Johnson Pharmaceutical Research & Development, LLC, Raritan, NJ, USA; 2Johnson & Johnson ...
Srihari Gopal +3 more
doaj +1 more source
Experience with the triple fixed combination in patients with chronic obstructive pulmonary disease
Chronic obstructive pulmonary disease (COPD) is one of the most important problems of modern medicine associated with a high mortality rate, high costs of treatment and relief of exacerbations of COPD.
I. V. Demko +4 more
doaj +1 more source
The cognitive effect of anticholinergics for patients with overactive bladder [PDF]
Overactive bladder (OAB) is often treated with medications that block the cholinergic receptors in the bladder (known as anticholinergics). The effect of this medication class on cognition and risk of dementia has been increasingly studied over the past ...
Richardson, Kathryn
core +3 more sources
New opportunities of dual bronchodilation therapy for patients with chronic obstructive pulmonary disease [PDF]
Currently, combinations of long-acting beta2-agonists and long-acting anticholinergics are considered as the basic therapy for majority of patients with chronic obstructive pulmonary disease (COPD).
S N Avdeev, N V Trushenko
doaj +1 more source
Contemporary management of pain in cirrhosis: Toward precision therapy for pain
Abstract Chronic pain is highly prevalent in patients with cirrhosis and is associated with poor health‐related quality of life and poor functional status. However, there is limited guidance on appropriate pain management in this population, and pharmacologic treatment can be harmful, leading to adverse outcomes, such as gastrointestinal bleeding ...
Alexis Holman +4 more
wiley +1 more source
Is there a rationale and role for long-acting anticholinergic bronchodilators in asthma? [PDF]
Despite current guidelines and the range of available treatments, over a half of patients with asthma continue to suffer from poor symptomatic control and remain at risk of future worsening. Although a number of non-pharmacological measures are crucial for good clinical management of asthma, new therapeutic controller medications will have a role in ...
Price, David +4 more
openaire +4 more sources

